{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:14:50Z","timestamp":1792692890038,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.amjms.2025.10.021","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T20:58:32Z","timestamp":1761339512000},"page":"313-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Virus-associated pulmonary aspergillosis: A rising challenge in respiratory infections"],"prefix":"10.1016","volume":"371","author":[{"given":"Amina","family":"Pervaiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.","family":"Soubani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2025.10.021_bib0001","unstructured":"WHO coronavirus disease (COVID-19) dashboard. 2024. https:\/\/data.who.int\/dashboards\/covid19\/cases (accessed March 1, 2024). https:\/\/www.who.int\/teams\/global-influenza-programme\/surveillance-and-monitoring\/influenza-surveillance-outputs."},{"issue":"9","key":"10.1016\/j.amjms.2025.10.021_bib0002","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study [published correction appears in Lancet Infect Dis. 2023 Oct;23(10):e400. Doi: 10.1016\/S1473-3099(23)00566-2]","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.021_bib0003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"166","key":"10.1016\/j.amjms.2025.10.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0114-2022","article-title":"Pulmonary aspergillosis: diagnosis and treatment","volume":"31","author":"Lamoth","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.021_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"van de Veerdonk","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2015.996132","article-title":"Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature","volume":"9","author":"Alshabani","year":"2015","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.021_bib0007","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33073\/pjm-2021-003","article-title":"The pathogenesis of Aspergillus fumigatus, host defense mechanisms, and the development of AFMP4 antigen as a vaccine","volume":"70","author":"Gu","year":"2021","journal-title":"Pol J Microbiol"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.021_bib0009","first-page":"1631","article-title":"Navigating the uncertainties of COVID-19-associated aspergillosis: a comparison with influenza-associated aspergillosis","volume":"224","author":"Lamoth","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.021_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4049\/jimmunol.2000067","article-title":"Influenza suppresses neutrophil recruitment to the lung and exacerbates secondary invasive pulmonary aspergillosis","volume":"205","author":"Tobin","year":"2020","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.021_bib0011","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.021_bib0012","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0013","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1097\/MJT.0000000000001617","article-title":"Tocilizumab and corticosteroids increase risk of COVID-19-associated pulmonary aspergillosis development among critically ill patients","volume":"30","author":"Awad","year":"2023","journal-title":"Am J Ther"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.021_bib0014","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.chest.2020.06.010","article-title":"Influenza-associated aspergillosis: nationwide trends, predictors and outcomes from 2005 to 2014","volume":"158","author":"Sharma","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/atm.atm_190_23","article-title":"Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States","volume":"19","author":"Sharma","year":"2024","journal-title":"Ann Thorac Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.021_bib0016","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.202310-1815VP","article-title":"Fungal fog in viral storms: necessity for rigor in aspergillosis diagnosis and research","volume":"209","author":"Feys","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12941-023-00626-7","volume":"22","author":"Estella","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob."},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13054-020-2808-8","volume":"24","author":"Thevissen","year":"2020","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0019","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, risk factors, clinical features, and outcome of Influenza-associated pulmonary aspergillosis in critically ill patients: a systematic review and meta-analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","article-title":"Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis [published correction appears in Lancet Respir Med. 2024 Jul;12(7):e42. Doi: 10.1016\/S2213-2600(24)00121-8.]","volume":"12","author":"Gioia","year":"2024","journal-title":"Lancet Respir Med."},{"issue":"10360","key":"10.1016\/j.amjms.2025.10.021_bib0021","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.021_bib0022","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0023","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A pathology-based case series of influenza- and COVID-19-associated pulmonary aspergillosis: the proof is in the tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.021_bib0024","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","article-title":"Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial","volume":"202","author":"Nyga","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2025.10.021_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bjaed\/mkw040","article-title":"Bronchoscopy in critical care","volume":"17","author":"Kabadayi","year":"2017","journal-title":"BJA Educ"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.021_bib0026","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis [published correction appears in PLoS One. 2017 Dec 27;12(12):e0190459. Doi: 10.1371\/journal.pone.0190459.]","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.021_bib0027","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"de Heer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delli\u00e8re","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.021_bib0029","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/arm91050027","article-title":"The clinical significance of Aspergillus detected in lower-Respiratory-tract samples of critically ill COVID-19-positive patients","volume":"91","author":"Osman","year":"2023","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.amjms.2025.10.021_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2022.855914","article-title":"Tracheal aspirate galactomannan testing in COVID-19-associated pulmonary aspergillosis","volume":"3","author":"Rom\u00e1n-Montes","year":"2022","journal-title":"Front Fungal Biol"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.021_bib0031","first-page":"499","article-title":"Serum 1,3-\u03b2-d-glucan for the early detection of invasive fungal diseases in patients with hematological malignancies undergoing intensive chemotherapy","volume":"59","author":"Prattes","year":"2016","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.021_bib0032","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/infdis\/jiad213","article-title":"Utility of plasma microbial cell-free DNA whole-genome sequencing for diagnosis of invasive aspergillosis in patients with hematologic malignancy or COVID-19","volume":"228","author":"Lee","year":"2023","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.021_bib0033","doi-asserted-by":"crossref","first-page":"e3876","DOI":"10.1093\/cid\/ciaa1639","article-title":"Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma","volume":"73","author":"Hill","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.021_bib0034","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/jof8070692","article-title":"Air sampling for fungus around hospitalized patients with coronavirus disease 2019","volume":"8","author":"Chen","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.021_bib0035","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3390\/diagnostics12071617","article-title":"Co-infections and superinfections in COVID-19 critically ill patients are associated with CT imaging abnormalities and the worst outcomes","volume":"12","author":"Brandi","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.021_bib0036","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in adult patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"issue":"10020","key":"10.1016\/j.amjms.2025.10.021_bib0037","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.021_bib0038","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0039","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/jof9030312","article-title":"Managing the next wave of influenza and\/or SARS-CoV-2 in the ICU-practical recommendations from an expert group for CAPA\/IAPA patients","volume":"9","author":"Peral","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.021_bib0040","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cmi.2019.04.031","article-title":"Intensive care management of influenza-associated pulmonary aspergillosis [published correction appears in Clin Microbiol Infect. 2020 Apr;26(4):527. Doi: 10.1016\/j.cmi.2019.12.022.]","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.021_bib0041","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.amjms.2025.10.021_bib0042","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.021_bib0043","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmi.2023.12.028","article-title":"Choosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence","volume":"30","author":"Sweeney","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.021_bib0044","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.021_bib0046","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.021_bib0047","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/myc.13328","article-title":"Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.021_bib0048","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.021_bib0049","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J Hosp Infect"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.021_bib0050","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2017.07.025","article-title":"Cytomegalovirus reactivation is associated with increased risk of late-onset invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a multicenter study in the current era of viral load monitoring","volume":"23","author":"Yong","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.021_bib0051","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02298-21","volume":"60","author":"Giacobbe","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.021_bib0052","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jmii.2021.03.005","article-title":"Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort study","volume":"55","author":"Kuo","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.021_bib0053","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.182.1.477","article-title":"Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor","volume":"182","author":"Frascaroli","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.021_bib0054","doi-asserted-by":"crossref","first-page":"ofab478","DOI":"10.1093\/ofid\/ofab478","article-title":"Invasive pulmonary aspergillosis complicating noninfluenza Respiratory viral infections in solid organ transplant recipients","volume":"8","author":"Apostolopoulou","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:19:28Z","timestamp":1773418768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0002962925012583"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.021","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-associated pulmonary aspergillosis: A rising challenge in respiratory infections","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}